Brown-Forman remains a Buy with steady sales, EPS growth, and a 3.5% dividend despite cautious outlook.

Brown-Forman is maintained as a Buy due to its attractive valuation amid macroeconomic challenges. The company shows resilience with flat organic sales, 6% earnings per share growth, strong cash flow, and a solid balance sheet supporting a 3.5% dividend yield. While guidance for fiscal year 2027 expects roughly flat organic sales and a 3-5% decline in operating income, ongoing innovation and restructuring efforts offer potential long-term growth. Additional catalysts include past buyout interest and premiumization trends, though risks from consumer weakness and margin pressures remain.